{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T16:26:50Z","timestamp":1768926410333,"version":"3.49.0"},"reference-count":57,"publisher":"Impact Journals, LLC","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2017,1,17]]},"DOI":"10.18632\/oncotarget.14146","type":"journal-article","created":{"date-parts":[[2016,12,27]],"date-time":"2016-12-27T19:25:59Z","timestamp":1482866759000},"page":"5349-5360","source":"Crossref","is-referenced-by-count":8,"title":["Guidance to rational use of pharmaceuticals in gallbladder sarcomatoid carcinoma using patient-derived cancer cells and whole exome sequencing"],"prefix":"10.18632","volume":"8","author":[{"given":"Feiling","family":"Feng","sequence":"first","affiliation":[{"name":"Department of Biliary I, Third Affiliated Hospital of PLA Second Military Medical University, Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingbao","family":"Cheng","sequence":"additional","affiliation":[{"name":"Department of Biliary I, Third Affiliated Hospital of PLA Second Military Medical University, Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liang","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Biliary I, Third Affiliated Hospital of PLA Second Military Medical University, Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dadong","family":"Zhang","sequence":"additional","affiliation":[{"name":"Division of Translational Medicine, 3D Medicines Corporation, Shanghai, China"},{"name":"Changhai Hospital, The Second Military Medical University, Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunlong","family":"Ji","sequence":"additional","affiliation":[{"name":"Division of Translational Medicine, 3D Medicines Corporation, Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiangzu","family":"Zhang","sequence":"additional","affiliation":[{"name":"Division of Translational Medicine, 3D Medicines Corporation, Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yihui","family":"Lin","sequence":"additional","affiliation":[{"name":"Division of Translational Medicine, 3D Medicines Corporation, Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fugen","family":"Li","sequence":"additional","affiliation":[{"name":"Division of Translational Medicine, 3D Medicines Corporation, Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Xiong","sequence":"additional","affiliation":[{"name":"Division of Translational Medicine, 3D Medicines Corporation, Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Biliary I, Third Affiliated Hospital of PLA Second Military Medical University, Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoqing","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Biliary I, Third Affiliated Hospital of PLA Second Military Medical University, Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2016,12,24]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"99","DOI":"10.2147\/CLEP.S37357","article-title":"Gallbladder cancer: epidemiology and outcome","volume":"6","author":"Shaffer","year":"2014","journal-title":"Clinical epidemiology"},{"key":"2","first-page":"349","article-title":"Nubia Mu\u00f1oz, Rolando Herrero, Catterina Ferrecio, Ignacio I.Wistuba","volume":"51","author":"Lazcano-Ponce","year":"2001","journal-title":"Patricia Alonso de Ruiz, Gerardo Aristi Urista, Flavio Nervi. Epidemiology and Molecular Pathology of Gallbladder Cancer. CA Cancer J Clin"},{"key":"3","first-page":"221","article-title":"Gallbladder cancer","volume":"3","author":"Busic","year":"2014","journal-title":"Hepatobiliary surgery and nutrition"},{"key":"4","first-page":"5","article-title":"Sarcomatoid carcinoma of the gall bladder","volume":"2","author":"Seenu","year":"2012","journal-title":"J Surg Case Rep"},{"key":"5","first-page":"7464","article-title":"Carcinosarcoma of the gallbladder: a case report and review of the literature","volume":"8","author":"Yunfeng","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"key":"6","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.gassur.2004.12.009","article-title":"Gallbladder carcinosarcoma: a case report and literature review","volume":"9","author":"Hewitt","year":"2005","journal-title":"J Gastrointest Surg"},{"key":"7","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1111\/j.1440-1827.2004.01771.x","article-title":"Sarcomatoid carcinoma with components of small cell carcinoma and undifferentiated carcinoma of the gallbladder","volume":"54","author":"Shiga","year":"2004","journal-title":"Pathol Int"},{"key":"8","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.3748\/wjg.15.1876","article-title":"Surgical management of gallbladder sarcomatoid carcinoma","volume":"15","author":"Liu","year":"2009","journal-title":"World journal of gastroenterology"},{"key":"9","first-page":"75","article-title":"Prognostic Significance of Race and Tumor Size in Carcinosarcoma of Gallbladder: a Meta-Analysis of 68 Cases","volume":"1","author":"Maoxin","year":"2008","journal-title":"Int J Clin Exp Pathol"},{"key":"10","doi-asserted-by":"crossref","unstructured":"Hotta, Yokoyama, Ura, Yamaue. So-called carcinosarcoma of the gallbladder; spindle cell carcinoma of the gallbladder: report of a case. 32. 2002; 5.","DOI":"10.1007\/s005950200077"},{"key":"11","doi-asserted-by":"crossref","first-page":"967472","DOI":"10.1155\/2015\/967472","article-title":"Gallbladder Cancer in the 21st Century","volume":"2015","author":"Kanthan","year":"2015","journal-title":"Journal of oncology"},{"key":"12","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1470-7330-14-14","article-title":"Imaging of malignancies of the biliary tract- an update","volume":"14","author":"Venkatesh","year":"2014","journal-title":"Cancer imaging"},{"key":"13","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.3748\/wjg.v22.i4.1335","article-title":"Molecular genetics and targeted therapeutics in biliary tract carcinoma","volume":"22","author":"Yee","year":"2016","journal-title":"World journal of gastroenterology"},{"key":"14","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1186\/1471-2407-10-631","article-title":"Targeting EGFR\/HER2 pathways enhances the antiproliferative effect of gemcitabine in biliary tract and gallbladder carcinomas","volume":"10","author":"Leone","year":"2010","journal-title":"BMC cancer"},{"key":"15","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1634\/theoncologist.2009-0302","article-title":"Current management of gallbladder carcinoma","volume":"15","author":"Kooby","year":"2010","journal-title":"The oncologist"},{"key":"16","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1475-2867-14-14","article-title":"Establishment and characterization of two primary breast cancer cell lines from young Indian breast cancer patients: mutation analysis","volume":"14","author":"Saxena","year":"2014","journal-title":"Cancer cell international"},{"key":"17","first-page":"775","article-title":"Establishment and characterization of a cell line, EH-GB2, derived from hepatic metastasis of gallbladder cancer","volume":"27","author":"Qian","year":"2012","journal-title":"Oncology reports"},{"key":"18","doi-asserted-by":"crossref","first-page":"e52485","DOI":"10.1371\/journal.pone.0052485","article-title":"Establishment, characterization and chemosensitivity of three mismatch repair deficient cell lines from sporadic and inherited colorectal carcinomas","volume":"7","author":"Linnebacher","year":"2012","journal-title":"PloS one"},{"key":"19","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.canlet.2013.08.041","article-title":"Establishment and characterization of a novel HPV-negative laryngeal squamous cell carcinoma cell line, FD-LSC-1, with missense and nonsense mutations of TP53 in the DNA-binding domain","volume":"342","author":"Li","year":"2014","journal-title":"Cancer letters"},{"key":"20","doi-asserted-by":"crossref","first-page":"e85308","DOI":"10.1371\/journal.pone.0085308","article-title":"Establishment and Characterization of 7 Novel Hepatocellular Carcinoma Cell Lines from Patient-Derived Tumor Xenografts","volume":"9","author":"Qin","year":"2014","journal-title":"PloS one"},{"key":"21","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/1475-2867-13-122","article-title":"Establishment of a bortezomib-resistant Chinese human multiple myeloma cell line: MMLAL","volume":"13","author":"Chim","year":"2013","journal-title":"Cancer cell international"},{"key":"22","first-page":"163","article-title":"Establishment of patient-derived non-small cell lung cancer xenograft models with genetic aberrations within EGFR, KRAS and FGFR1: useful tools for preclinical studies of targeted therapies","volume":"11","author":"Zhan","year":"2013","journal-title":"Journal of Translational Medicine"},{"key":"23","first-page":"127ps110","article-title":"Intratumor heterogeneity: seeing the wood for the trees","volume":"4","author":"Swanton","year":"2012","journal-title":"Sci Transl Med"},{"key":"24","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1158\/2159-8274.CD-11-0005","article-title":"Mutations in the DDR2 kinase gene identify a novel therapeutic target in squamous cell lung cancer","volume":"1","author":"Lawrence","year":"2011","journal-title":"Cancer discovery"},{"key":"25","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1126\/science.1235122","article-title":"Cancer genome landscapes","volume":"339","author":"Kinzler","year":"2013","journal-title":"Science"},{"key":"26","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/nature12634","article-title":"Mutational landscape and significance across 12 major cancer types","volume":"502","author":"Ley","year":"2013","journal-title":"Nature"},{"key":"27","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1038\/ng.3030","article-title":"Whole-exome and targeted gene sequencing of gallbladder carcinoma identifies recurrent mutations in the ErbB pathway","volume":"46","author":"Liu","year":"2014","journal-title":"Nat Genet"},{"key":"28","doi-asserted-by":"publisher","first-page":"2839","DOI":"10.18632\/oncotarget.1943","article-title":"Multigene mutational profiling of cholangiocarcinomas identifies actionable molecular subgroups","volume":"5","author":"Antonello","year":"2014","journal-title":"Oncotarget"},{"key":"29","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1126\/science.1254721","article-title":"Patient-derived models of acquired resistance can identify effective drug combinations for cancer","volume":"346","author":"Capelli","year":"2014","journal-title":"Science"},{"key":"30","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1200\/JCO.2007.14.8494","article-title":"First-line gefitinib in patients with advanced non-small-cell lung cancer harboring somatic EGFR mutations","volume":"26","author":"Engelman","year":"2008","journal-title":"Journal of clinical oncology"},{"key":"31","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1056\/NEJMoa1006448","article-title":"Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer","volume":"363","author":"Fidias","year":"2010","journal-title":"N Engl J Med"},{"key":"32","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1056\/NEJMoa1103782","article-title":"Improved survival with vemurafenib in melanoma with BRAF V600E mutation","volume":"364","author":"Ribas","year":"2011","journal-title":"N Engl J Med"},{"key":"33","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1056\/NEJMoa0708857","article-title":"SHARP Investigators Study Group. Sorafenib in Advanced Hepatocellular Carcinoma","volume":"359","author":"Bolondi","year":"2008","journal-title":"N Engl J Med"},{"key":"34","doi-asserted-by":"crossref","first-page":"5601","DOI":"10.1200\/JCO.2006.08.5415","article-title":"Targeted therapy for metastatic renal cell carcinoma","volume":"24","author":"Motzer","year":"2006","journal-title":"Journal of clinical oncology"},{"key":"35","first-page":"382723","article-title":"Embryonal sarcoma of the liver in an adult patient","volume":"2012","author":"Nikfarjam","year":"2012","journal-title":"Case reports in surgery"},{"key":"36","first-page":"274","article-title":"Testicular synovial sarcoma: a case report","volume":"9","author":"Mezlini","year":"2012","journal-title":"Cancer biology & medicine"},{"key":"37","first-page":"19","article-title":"Blue Cell Tumour at Unusual Site: Retropritoneal Ewings Sarcoma","volume":"10","author":"Palur","year":"2016","journal-title":"Journal of Clinical and Diagnostic Research"},{"key":"38","article-title":"Endometrial stromal sarcoma of the uterus presenting as pulmonary metastasis","author":"Bovanlu","year":"2013","journal-title":"BMJ case reports"},{"key":"39","doi-asserted-by":"crossref","first-page":"7357","DOI":"10.1158\/0008-5472.CAN-09-0064","article-title":"Identification of novel gene amplifications in breast cancer and coexistence of gene amplification with an activating mutation of PIK3CA","volume":"69","author":"Lee","year":"2009","journal-title":"Cancer research"},{"key":"40","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/1471-2407-12-50","article-title":"Highly frequent PIK3CA amplification is associated with poor prognosis in gastric cancer","volume":"12","author":"Hou","year":"2012","journal-title":"BMC cancer"},{"key":"41","doi-asserted-by":"crossref","first-page":"e103021","DOI":"10.1371\/journal.pone.0103021","article-title":"PIK3CA gene mutations and overexpression: implications for prognostic biomarker and therapeutic target in Chinese esophageal squamous cell carcinoma","volume":"9","author":"Lu","year":"2014","journal-title":"PloS one"},{"key":"42","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1186\/1471-2407-11-147","article-title":"Cuixia Gao, Bingyin Shi, Peng Hou. Highly frequent promoter methylation and PIK3CA amplification in non-small cell lung cancer(NSCLC)","volume":"11","author":"Meiju Ji","year":"2011","journal-title":"BMC cancer"},{"key":"43","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1186\/1471-2407-12-416","article-title":"Copy Number Amplification of the PIK3CA Gene Is Associated with Poor Prognosis in Non-lymph node metastatic Head and Neck Squamous Cell Carcinoma","volume":"12","author":"Hiroshi","year":"2012","journal-title":"BMC cancer"},{"key":"44","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/j.celrep.2014.06.053","article-title":"Intratumor DNA methylation heterogeneity reflects clonal evolution in aggressive prostate cancer","volume":"8","author":"Schlomm","year":"2014","journal-title":"Cell reports"},{"key":"45","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1113205","article-title":"Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing","volume":"366","author":"Phillimore","year":"2012","journal-title":"N Engl J Med"},{"key":"46","doi-asserted-by":"crossref","first-page":"4009","DOI":"10.1073\/pnas.1219747110","article-title":"Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics","volume":"110","author":"Tavare","year":"2013","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"47","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1593\/neo.131400","article-title":"Tumor Evolution and Intratumor Heterogeneity of an Oropharyngeal Squamous Cell Carcinoma Revealed by Whole-Genome Sequencing","volume":"15","author":"Zhao","year":"2013","journal-title":"Neoplasia"},{"key":"48","doi-asserted-by":"crossref","unstructured":"Morris, Riaz, Desrichard, \u015eenbabao\u011flu, Hakimi, Makarov, Reis-Filho, Chan. Oncotarget. 2016; 7:10051\u201310063. https:\/\/doi.org\/10.18632\/oncotarget.7067.","DOI":"10.18632\/oncotarget.7067"},{"key":"49","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.3892\/ol.2015.3460","article-title":"Sarcomatoid carcinoma of the stomach: A case report and literature review","volume":"10","author":"Zhao","year":"2015","journal-title":"Oncology letters"},{"key":"50","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/1471-2407-11-60","article-title":"Mutational profiling reveals PIK3CA mutations in gallbladder carcinoma","volume":"11","author":"Hezel","year":"2011","journal-title":"BMC cancer"},{"key":"51","doi-asserted-by":"crossref","first-page":"4822","DOI":"10.1158\/0008-5472.CAN-14-0584","article-title":"Definition of PKC-alpha, CDK6, and MET as therapeutic targets in triple-negative breast cancer","volume":"74","author":"Sahin","year":"2014","journal-title":"Cancer research"},{"key":"52","doi-asserted-by":"crossref","first-page":"e98293","DOI":"10.1371\/journal.pone.0098293","article-title":"Identification of druggable cancer driver genes amplified across TCGA datasets","volume":"9","author":"Kouros-Mehr","year":"2014","journal-title":"PloS one"},{"key":"53","doi-asserted-by":"crossref","first-page":"790","DOI":"10.7150\/jca.9794","article-title":"Amplification of Chromosome 1q Genes Encoding the Phosphoinositide Signalling Enzymes PI4KB, AKT3, PIP5K1A and PI3KC2B in Breast Cancer","volume":"5","author":"Waugh","year":"2014","journal-title":"Journal of Cancer"},{"key":"54","doi-asserted-by":"crossref","first-page":"ra12","DOI":"10.1126\/scisignal.aad3210","article-title":"ABL kinases promote breast cancer osteolytic metastasis by modulating tumor-bone interactions through TAZ and STAT5 signaling","volume":"9","author":"Pendergast","year":"2016","journal-title":"Science signaling"},{"key":"55","doi-asserted-by":"crossref","first-page":"5724","DOI":"10.1158\/1078-0432.CCR-08-3215","article-title":"Phosphatidylinositol 3\u2032-kinase catalytic subunit alpha gene amplification contributes to the pathogenesis of mantle cell lymphoma","volume":"15","author":"Economopoulos","year":"2009","journal-title":"Clin Cancer Res"},{"key":"56","doi-asserted-by":"crossref","first-page":"R609","DOI":"10.1186\/bcr1262","article-title":"Somatic mutation and gain of copy number of PIK3CA in human breast cancer","volume":"7","author":"Sidransky","year":"2005","journal-title":"Breast cancer research"},{"key":"57","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.cell.2016.06.017","article-title":"A Landscape of Pharmacogenomic Interactions in Cancer","volume":"166","author":"Heyn","year":"2016","journal-title":"Cell"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.14146","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,21]],"date-time":"2024-06-21T13:01:03Z","timestamp":1718974863000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.14146"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,24]]},"references-count":57,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,1,17]]}},"alternative-id":["14146","28029662"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.14146","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,24]]}}}